ArticleJournal of translational medicine2025

CXCL12 deficiency promotes colorectal cancer progression and reduces anti-PD-L1 immunotherapy efficacy through MDSC regulation.

Heping Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.